Dybbs Michael
CIK: 0001601264
Director
Primary company: SUTRO BIOPHARMA, INC. (STRO)
Dybbs Michael is a corporate insider at SUTRO BIOPHARMA, INC. (STRO) filing SEC Form 4 transactions. 22 transactions across 5 companies, totaling $12,499,994 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
Nkarta, Inc. NKTX | Award | 37,000 | $2.46 | $91K | 37,000 | 6/10/2026 Filed: 6/10/2026 | Filing → |
| Award | 9,000 | $4.72 | $42K | 9,000 | 6/3/2026 Filed: 6/3/2026 | Filing → | |
| Award | 1,500 | - | - | 1,500 | 12/23/2025 Filed: 12/29/2025 | Filing → | |
| Award | 50,000 | - | - | 50,000 | 6/6/2025 Filed: 6/10/2025 | Filing → | |
Nkarta, Inc. NKTX | Award | 46,000 | - | - | 46,000 | 6/5/2025 Filed: 6/9/2025 | Filing → |
| Award | 18,000 | - | - | 18,000 | 4/10/2025 Filed: 4/11/2025 | Filing → | |
Nkarta, Inc. NKTX | Award | 22,500 | - | - | 22,500 | 6/13/2024 Filed: 6/14/2024 | Filing → |
| Award | 35,000 | - | - | 35,000 | 6/6/2024 Filed: 6/10/2024 | Filing → | |
| Award | 25,000 | $0.00 | $0 | 25,000 | 6/8/2023 Filed: 6/12/2023 | Filing → | |
Nkarta, Inc. NKTX | Award | 22,500 | $0.00 | $0 | 22,500 | 6/7/2023 Filed: 6/9/2023 | Filing → |
Nkarta, Inc. NKTX | Award | 16,000 | $0.00 | $0 | 16,000 | 6/8/2022 Filed: 6/10/2022 | Filing → |
| Award | 18,500 | $0.00 | $0 | 18,500 | 6/6/2022 Filed: 6/8/2022 | Filing → | |
Nkarta, Inc. NKTX | Award | 16,511 | $0.00 | $0 | 16,511 | 6/13/2021 Filed: 6/15/2021 | Filing → |
| Award | 18,500 | $0.00 | $0 | 18,500 | 6/3/2021 Filed: 6/7/2021 | Filing → | |
Nkarta, Inc. NKTX | Award | 10,700 | $0.00 | $0 | 10,700 | 7/9/2020 Filed: 7/13/2020 | Filing → |
| Award | 12,000 | $0.00 | $0 | 12,000 | 6/5/2020 Filed: 6/8/2020 | Filing → | |
| Award | 11,610 | $0.00 | $0 | 11,610 | 6/17/2019 Filed: 6/19/2019 | Filing → | |
| Award | 26,033 | $0.00 | $0 | 26,033 | 9/26/2018 Filed: 9/27/2018 | Filing → | |
Dimension Therapeutics, Inc. DMTX | Award | 17,000 | $0.00 | $0 | 17,000 | 5/25/2017 Filed: 5/26/2017 | Filing → |
Dimension Therapeutics, Inc. DMTX | Award | 32,069 | $0.00 | $0 | 32,069 | 5/19/2016 Filed: 5/23/2016 | Filing → |
Nkarta, Inc.
NKTX
Type
Award
Shares
37,000
Price
$2.46
Value
$91K
Type
Award
Shares
9,000
Price
$4.72
Value
$42K
Type
Award
Shares
1,500
Price
-
Value
-
Type
Award
Shares
50,000
Price
-
Value
-
Nkarta, Inc.
NKTX
Type
Award
Shares
46,000
Price
-
Value
-
Type
Award
Shares
18,000
Price
-
Value
-
Nkarta, Inc.
NKTX
Type
Award
Shares
22,500
Price
-
Value
-
Type
Award
Shares
35,000
Price
-
Value
-
Type
Award
Shares
25,000
Price
$0.00
Value
$0
Nkarta, Inc.
NKTX
Type
Award
Shares
22,500
Price
$0.00
Value
$0
Nkarta, Inc.
NKTX
Type
Award
Shares
16,000
Price
$0.00
Value
$0
Type
Award
Shares
18,500
Price
$0.00
Value
$0
Nkarta, Inc.
NKTX
Type
Award
Shares
16,511
Price
$0.00
Value
$0
Type
Award
Shares
18,500
Price
$0.00
Value
$0
Nkarta, Inc.
NKTX
Type
Award
Shares
10,700
Price
$0.00
Value
$0
Type
Award
Shares
12,000
Price
$0.00
Value
$0
Type
Award
Shares
11,610
Price
$0.00
Value
$0
Type
Award
Shares
26,033
Price
$0.00
Value
$0
Dimension Therapeutics, Inc.
DMTX
Type
Award
Shares
17,000
Price
$0.00
Value
$0
Dimension Therapeutics, Inc.
DMTX
Type
Award
Shares
32,069
Price
$0.00
Value
$0
AI Agent
Try asking...